PHARMACOKINETICS AND PHARMACODYNAMICS OF IV AND ORAL FORMULATIONS OF CG-745 AFTER A SINGLE ADMINISTRATION IN HEALTHY KOREAN SUBJECTS

被引：0
|
作者：
Kim, B. [1 ]
Bae, S. [1 ]
Park, S. [1 ]
Jang, I [1 ]
Oh, J. [1 ]
Cho, S. [2 ]
Kim, Y. [2 ]
Lee, S. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med & Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
[2] CrystalGenomics Inc, Div Clin Dev, Korea Bio Pk, Seongnam Si, South Korea
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2022年 / 78卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
51
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics, pharmacodynamics and safety of oral formulation (CG-750) of ivaltinostat, a histone deacetylase inhibitor, compared to IV formulation (CG-745)
    Kim, Byungwook
    Huh, Ki Young
    Yu, Kyung-Sang
    Lee, Seunghwan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (04) : 1103 - 1114
  • [2] Pharmacokinetics and pharmacodynamics of clomethiazole after oral and rectal administration in healthy subjects
    Rätz, AE
    Schlienger, RG
    Linder, L
    Langewitz, W
    Haefeli, WE
    CLINICAL THERAPEUTICS, 1999, 21 (05) : 829 - 840
  • [3] Pharmacokinetics and pharmacodynamics of LC15-0444, a novel DPP IV inhibitor, after single oral administration in healthy subjects.
    Choi, Y. J.
    Lim, K. S.
    Kim, K. P.
    Cho, J. Y.
    Yu, K. S.
    Shin, S. G.
    Yim, H. J.
    Kwon, O. H.
    Lee, J. I.
    Kim, D. K.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S88 - S88
  • [4] PHARMACOKINETICS AND PHARMACODYNAMICS OF ALPRAZOLAM AFTER ORAL AND IV ADMINISTRATION
    SMITH, RB
    KROBOTH, PD
    VANDERLUGT, JT
    PHILLIPS, JP
    JUHL, RP
    PSYCHOPHARMACOLOGY, 1984, 84 (04) : 452 - 456
  • [5] Pharmacokinetics and bioequivalence of two strontium ranelate formulations after single oral administration in healthy Chinese subjects
    Zhang, Dan
    Du, Aihua
    Wang, Xiaolin
    Zhang, Lina
    Yang, Man
    Ma, Jingyi
    Deng, Ming
    Liu, Huichen
    XENOBIOTICA, 2019, 49 (04) : 457 - 462
  • [6] Pharmacokinetics and pharmacodynamics of tepoxalin after single oral dose administration to healthy volunteers
    Waldman, SA
    Vitow, C
    Osborne, B
    Gillen, L
    Argentieri, DC
    Wong, FA
    Smith, IL
    Chow, AT
    Misiti, J
    Bjornsson, TD
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (05): : 462 - 468
  • [7] Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Domperidone After Single-Dose Administration in Healthy Chinese Subjects
    Ye, Libing
    Shen, Minmin
    Chen, Yingrong
    Li, Xiaofeng
    Xu, Min
    Yao, Chong
    Yang, Shuixin
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09): : 1084 - 1091
  • [8] Pharmacokinetics and bioequivalence of two oral formulations of canagliflozin after single-dose administration in healthy Chinese subjects
    Hu, Wei
    Yang, Yaru
    Zhang, Qian
    Yang, Yang
    Zhou, Renpeng
    Lu, Chao
    Liu, Zeyuan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (01) : 57 - 66
  • [9] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VALBENAZINE AFTER SINGLE AND MULTIPLE ORAL ADMINISTRATION IN HEALTHY KOREAN MALE SUBJECTS.
    Chung, W.
    Huh, K.
    Ka, J.
    Bae, S.
    Oh, J.
    Yoon, S.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S15 - S15
  • [10] Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects
    Kroesser, S.
    Tillner, J.
    Fluck, M.
    Ungethuem, W.
    Wolna, P.
    Kovar, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (05) : 271 - 280
12345